JPMORGAN CHASE & CO - REPARE THERAPEUTICS INC ownership

REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 75 filers reported holding REPARE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.7%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of REPARE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$98,464
+513.1%
8,151
+437.0%
0.00%
Q2 2023$16,061
+7.1%
1,518
+2.6%
0.00%
Q1 2023$15,000
+71328.6%
1,479
+2.0%
0.00%
Q4 2022$21
-100.0%
1,450
-93.8%
0.00%
Q3 2022$282,000
-9.3%
23,221
+4.7%
0.00%
Q2 2022$311,000
-12.6%
22,175
-11.4%
0.00%
Q1 2022$356,000
-29.1%
25,039
+5.3%
0.00%
Q4 2021$502,000
-33.1%
23,786
-16.7%
0.00%
Q3 2021$750,000
+1239.3%
28,554
+1496.1%
0.00%
Q2 2021$56,000
-99.0%
1,789
-99.0%
0.00%
-100.0%
Q1 2021$5,662,000
+566100.0%
184,477
+683148.1%
0.00%
Q4 2020$1,000270.00%
Other shareholders
REPARE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,242,636$22,067,5389.20%
CHI Advisors LLC 2,997,939$29,499,7197.83%
MPM BioImpact LLC 1,639,849$16,136,1144.19%
BVF INC/IL 8,291,988$81,593,1622.98%
HighVista Strategies LLC 164,890$1,622,5181.32%
Sio Capital Management, LLC 228,538$2,248,8141.11%
Deep Track Capital, LP 2,727,606$26,839,6431.10%
Redmile Group, LLC 2,533,050$24,925,2121.08%
Orbimed Advisors 3,322,488$32,693,2820.64%
Artal Group S.A. 700,000$6,8880.41%
View complete list of REPARE THERAPEUTICS INC shareholders